JPH0539225A - Medicine for external use - Google Patents
Medicine for external useInfo
- Publication number
- JPH0539225A JPH0539225A JP3196708A JP19670891A JPH0539225A JP H0539225 A JPH0539225 A JP H0539225A JP 3196708 A JP3196708 A JP 3196708A JP 19670891 A JP19670891 A JP 19670891A JP H0539225 A JPH0539225 A JP H0539225A
- Authority
- JP
- Japan
- Prior art keywords
- skin
- blood circulation
- shea
- external use
- medicine
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Granted
Links
Landscapes
- Medicinal Preparation (AREA)
- Cosmetics (AREA)
- Medicines Containing Plant Substances (AREA)
Abstract
Description
【0001】[0001]
【産業上の利用分野】本発明は外用剤に関し、更に詳細
には皮膚に塗布することにより当該皮膚の血行を促進
し、皮膚温を上昇・保持する作用を有する外用薬剤に関
する。BACKGROUND OF THE INVENTION 1. Field of the Invention The present invention relates to an external preparation, and more particularly to an external preparation having the action of promoting blood circulation in the skin and increasing / maintaining the skin temperature when applied to the skin.
【0002】[0002]
【従来の技術】皮膚の血行不良に起因する疾患として、
肌あれ、シモヤケ、冷え症等がある。これらの疾患の治
療剤としては、種々の油剤、保湿剤等を配合した軟膏
剤、クリーム等が広く用いられている。2. Description of the Related Art As a disease caused by poor blood circulation in the skin,
There are rough skin, frostiness, and chills. As therapeutic agents for these diseases, ointments and creams containing various oils, humectants and the like are widely used.
【0003】[0003]
【発明が解決しようとする課題】しかしながら、従来の
軟膏剤やクリームは、単に油剤や保湿剤を皮膚に供給す
ることにより皮膚の自然治癒作用を促すものが多く、そ
の根本原因である皮膚の血行不良を改善する作用を有す
るものはほとんどなかった。一方、皮膚の血行を促進す
る作用を有する物質は、数多く知られているが、外用で
の有効性及び安全性の面から、外用剤に適用できるもの
はほとんどなかった。従って、本発明の目的は、安全性
が高く、外用で有効な血行促進剤を提供することにあ
る。However, many of the conventional ointments and creams promote the natural healing action of the skin by simply supplying an oil or moisturizer to the skin, and the blood circulation of the skin which is the root cause thereof. Almost no one had the effect of improving defects. On the other hand, many substances having an action of promoting blood circulation in the skin are known, but from the viewpoint of effectiveness and safety for external use, almost none of them can be applied to external preparations. Therefore, an object of the present invention is to provide a blood circulation promoter having high safety and being effective for external use.
【0004】[0004]
【課題を解決するための手段】かかる実情において本発
明者らは安全性の高い各種の植物性油脂についてその薬
理作用を検討した結果、シアの種子より得られる油脂を
皮膚に塗布すれば、血行促進に基づく、優れた皮膚温上
昇・保持効果が得られることを見出し、本発明を完成し
た。Under the circumstances, the present inventors have studied the pharmacological action of various highly safe vegetable oils and fats, and as a result, when the oils and fats obtained from seeds of shea are applied to the skin, blood circulation is improved. The present invention has been completed by finding that an excellent effect of raising and maintaining skin temperature based on promotion can be obtained.
【0005】すなわち、本発明はシアの種子より得られ
る油脂を有効成分とする外用血行促進剤を提供するもの
である。That is, the present invention provides an external blood circulation promoting agent containing oil and fat obtained from shea seeds as an active ingredient.
【0006】本発明の血行促進剤の有効成分であるシア
の種子より得られる油脂は、主に中央アフリカに分布す
るシアの木(Butyrospermum Parki
i)の種子から抽出される植物性油脂である。The oil and fat obtained from the seeds of shea, which is an active ingredient of the blood circulation promoting agent of the present invention, is a shea tree (Butyrospermum Parki) mainly distributed in Central Africa.
It is a vegetable oil or fat extracted from the seed of i).
【0007】従来、シアの種子より得られる油脂につい
ては、食品、化粧品基剤としての用途〔Perfume
s. Cosmet. Aromes., 58 p6
5〜66(1984)〕、紫外線吸収作用、日焼防止剤
としての用途〔NATO ASI Ser., 181
p267〜276(1990),特公昭58−433
63号〕、鼻粘膜の充血除去作用〔Br. J. Cl
in. Pharmacol., 7(5) p495
〜497(1979)〕等についての報告があるが、血
行促進作用があることは全く知られていない。Conventionally, oils and fats obtained from shea seeds have been used as food and cosmetic bases [Perfume.
s. Cosmet. Aromes. , 58 p6
5 to 66 (1984)], an ultraviolet absorbing effect, and use as a sunscreen agent [NATO ASI Ser. , 181
p267-276 (1990), Japanese Patent Publication No. 58-433
63], decongesting action of nasal mucosa [Br. J. Cl
in. Pharmacol. , 7 (5) p495
~ 497 (1979)] and the like, but it is not known at all that it has a blood circulation promoting action.
【0008】シアの種子より油脂(以下、「シア脂」と
略す)を抽出するには、自体公知の手段、例えば、シア
の種子を温時圧搾する、水を加えて煮つめる等の方法を
採用すればよい。なお、このシア脂は、シアバター(S
hea Butter)及びシアバターコンク(She
a Unsaponifiable)のグレードのもの
が、例えばビオデルマSX−19、ビオデルマSX−2
0(いずれもセデルマ社)、シアバター45デオ(ヘン
ケル社)等として市販されている。また、これら市販の
シア脂を更に活性炭処理することにより、無着色、無臭
化したものを用いるのが好ましい。本発明に用いるシア
脂の性状は、例えば以下の如くであり、その組成につい
ては、J. Assoc. Off. Anal. C
hem., 50(6)p1335〜1338に記載さ
れている。 比重(d) 0.91〜0.98 屈折率(n) 1.450〜1.480 融点(℃) 25〜45 ケン化価 140〜190 ヨウ素価 50〜85 不ケン化物(%) 4以上To extract oils and fats (hereinafter, abbreviated as "shea butter") from the seeds of shea, a method known per se, for example, a method of squeezing the seeds of warm at a warm time, adding water and boiling it, etc. is adopted. do it. The shea butter is shea butter (S
shea butter) and shea butter conc (She
a Unsaponifiable) grade, for example, Bioderma SX-19, Bioderma SX-2
No. 0 (both are manufactured by Sederma) and Shea Butter 45 Deo (Henkel) are commercially available. Further, it is preferable to use those which are uncolored and deodorized by further treating these commercially available shea fat with activated carbon. The properties of the shea fat used in the present invention are, for example, as follows. Assoc. Off. Anal. C
hem. , 50 (6) p1335-1338. Specific gravity (d) 0.91 to 0.98 Refractive index (n) 1.450 to 1.480 Melting point (° C) 25 to 45 Saponification value 140 to 190 Iodine value 50 to 85 Unsaponifiables (%) 4 or more
【0009】本発明外用血行促進剤へのシア脂の配合量
は、特に限定されないが、0.1〜9.5重量%が好ま
しい。The blending amount of the shea fat in the external blood circulation promoting agent of the present invention is not particularly limited, but is preferably 0.1 to 9.5% by weight.
【0010】また、本発明外用血行促進剤には、シア脂
以外に通常外用医薬品、医薬部外品、化粧料等に使用さ
れる他の成分を発明の効果を損なわない範囲で配合する
ことができる。かかる成分としては、例えば水、他の薬
効成分、他の油剤、保湿剤、界面活性剤、紫外線吸収
剤、吸収促進剤、香料、色素、保存剤等を挙げることが
できる。ここで他の薬効成分としては、消炎鎮痛剤、抗
ヒスタミン剤、止痒剤、殺菌剤、ビタミン剤、ホルモン
剤等が挙げられる。In addition to the shea butter, other components commonly used in external medicines, quasi drugs, cosmetics and the like may be added to the external blood circulation promoting agent of the present invention within a range that does not impair the effects of the invention. it can. Examples of such components include water, other medicinal components, other oils, moisturizers, surfactants, ultraviolet absorbers, absorption promoters, fragrances, dyes, preservatives and the like. Examples of other medicinal components include anti-inflammatory analgesics, antihistamines, antipruritics, bactericides, vitamins and hormones.
【0011】本発明外用血行促進剤は、常法によりシア
脂と他の成分を混合して調製することができ、その剤型
としては軟膏剤、クリーム剤、ゲル、ローション等が挙
げられる。The external blood circulation promoting agent of the present invention can be prepared by mixing shea butter and other components by a conventional method, and its dosage form includes ointments, creams, gels, lotions and the like.
【0012】[0012]
【発明の効果】本発明によれば、皮膚に塗布することに
より、当該塗布部位の皮膚の血行が促進される結果、皮
膚温が上昇し、かつその作用が持続するため、肌あれ、
シモヤケ、冷え症等を容易に治療することができる。EFFECTS OF THE INVENTION According to the present invention, by applying to the skin, the blood circulation of the application site is promoted, resulting in an increase in skin temperature and a continuous action thereof, and
It is possible to easily treat blemishes and chills.
【0013】[0013]
【実施例】次に実施例を挙げて本発明を詳細に説明する
が、本発明はこれに限定されるものではない。EXAMPLES The present invention will now be described in detail with reference to examples, but the present invention is not limited thereto.
【0014】試験例1 (方法)室温23℃の測定室に被験者を30分以上安静
に保たせた後、医用サーモグラフィー装置(日本光電、
INFRA−EYE 180型)により両手の甲の皮膚
温を測定しカラービデオプリンターにより記録した。両
手甲の皮膚温がほぼ同じで安定した被験者5名に対し、
一方の甲にシア脂(ヘンケル社製)を、他方には日本薬
局方オリーブ油を、それぞれ約0.5g塗布し全体にの
ばし軽く擦り込んだ。この際被験者には塗布薬剤を知ら
せなかった。 (1)塗布後60分まで経時的に皮膚温を測定、記録し
た。次に、60分後の観察終了後直ちに16℃の水中に
10秒間両手を浸した。 (2)水を拭き取った後経時的に皮膚温を測定、記録し
た。 (結果) (1)塗布後30〜60分において、シア脂塗布側が、
5例中4例において高い皮膚温を示した。 (2)水冷後の皮膚温は両手とも著しく低下したが、5
〜30分にわたる回復過程においてもシア脂塗布側の皮
膚温が、5例中4例において高値を示した。Test Example 1 (Method) After a subject was kept at rest in a measuring room at room temperature of 23 ° C. for 30 minutes or more, a medical thermography device (Nihon Kohden,
The skin temperature of the backs of both hands was measured by INFRA-EYE 180 type) and recorded by a color video printer. For 5 subjects with stable skin temperature on both backs,
About 0.5 g of shea butter (manufactured by Henkel Co., Ltd.) was applied to one instep and about 0.5 g of Japanese Pharmacopoeia olive oil was applied to the other, and the whole was lightly rubbed. At this time, the test subject was not informed of the applied drug. (1) The skin temperature was measured and recorded over time up to 60 minutes after application. Then, immediately after the observation was completed after 60 minutes, both hands were immersed in 16 ° C. water for 10 seconds. (2) After the water was wiped off, the skin temperature was measured and recorded over time. (Results) (1) 30 to 60 minutes after coating,
High skin temperature was shown in 4 out of 5 cases. (2) The skin temperature after water cooling decreased significantly in both hands, but
The skin temperature on the shea fat application side showed a high value in 4 out of 5 cases even during the recovery process over ˜30 minutes.
【0015】試験例2 試験例1と同様の条件下で左手甲に対照としてオリーブ
油を、右手甲にシア脂(ヘンケル社製)をそれぞれ約
0.5g塗布し、16℃の水道水により10秒間冷却
し、その後室温で放置して、医用サーモグラフィー装置
により皮膚温を測定した。その結果、図1及び図2に示
すようにシア脂を塗布した右手は、オリーブ油を塗布し
た左手に比べ明らかに皮膚温が上昇していた。Test Example 2 Under the same conditions as in Test Example 1, about 0.5 g of olive oil was applied to the left back as a control, and about 0.5 g of shea butter (made by Henkel) was applied to the right back, and tap water at 16 ° C. for 10 seconds. It was cooled and then left at room temperature and the skin temperature was measured by a medical thermography device. As a result, as shown in FIGS. 1 and 2, the skin temperature of the right hand coated with shea butter was clearly higher than that of the left hand coated with olive oil.
【0016】実施例1(クリーム) (組成) (重量%) a)グリセリンモノステアリル 1.5 オリーブ油 5.0 シアバター(ヘンケル社製) 5.0 スクワラン 4.0 b)ステアリン酸 9.0 グリセリン 10.0 水酸化ナトリウム 0.25 精製水 65.25 成分a)及びb)をそれぞれ80℃に加温する。撹拌し
ながら成分a)に成分b)を添加した後、室温まで冷却
し、クリーム剤とする。Example 1 (Cream) (Composition) (% by weight) a) Glycerin monostearyl 1.5 Olive oil 5.0 Shea butter (manufactured by Henkel) 5.0 Squalane 4.0 b) Stearic acid 9.0 Glycerin 10.0 Sodium hydroxide 0.25 Purified water 65.25 Components a) and b) are each heated to 80 ° C. After adding component b) to component a) with stirring, cool to room temperature to give a cream.
【0017】実施例2(軟膏) (組成) (重量%) a)白色ワセリン 20.0 シアバター(セデルマ社製) 10.0 流動パラフィン 8.0 セタノール 2.0 ポリオキシエチレンセチルエーテル 2.5 b)プロピレングリコール 5.0 精製水 52.5 成分a)及びb)をそれぞれ80℃に加温する。撹拌し
ながら成分a)に成分b)を添加した後、室温まで冷却
し、軟膏を製造する。Example 2 (Ointment) (Composition) (wt%) a) White petrolatum 20.0 Shea butter (manufactured by Sederma) 10.0 Liquid paraffin 8.0 Cetanol 2.0 Polyoxyethylene cetyl ether 2.5 b) Propylene glycol 5.0 Purified water 52.5 Components a) and b) are each heated to 80 ° C. After adding the component b) to the component a) with stirring, the mixture is cooled to room temperature to produce an ointment.
【0018】実施例3(ゲル) (組成) (重量%) a)プロピレングリコール 12.0 エタノール 20.0 シアバター(セデルマ社製) 0.6 b)カーボポール934 1.0 ジイソプロパノールアミン 0.5 エタノール 30.0 精製水 35.9 カーボポール934をエタノールに分散した後、撹拌し
ながら精製水に溶かしたジイソプロパノールアミンを少
量ずつ添加し、全体を均一に懸濁させる。この液に、撹
拌しながら成分a)を添加し、全体を均一なゲルとす
る。Example 3 (Gel) (Composition) (wt%) a) Propylene glycol 12.0 Ethanol 20.0 Shea butter (manufactured by Sederma) 0.6 b) Carbopol 934 1.0 Diisopropanolamine 0. 5 Ethanol 30.0 Purified water 35.9 Carbopol 934 is dispersed in ethanol, and then diisopropanolamine dissolved in purified water is added little by little while stirring to uniformly suspend the whole. Component a) is added to this liquid with stirring to make a uniform gel.
【0019】実施例4(リップクリーム) (組成) (重量%) キャンデリラロウ 20.0 カルナバロウ 2.0 シアバター(ヘンケル社製) 7.0 硬化ヒマシ油 2.0 マイクロクリスタリンワックス 1.0 ヒマシ油 68.0 各成分を80℃で加温溶融した後に型に入れ、室温まで
冷却する。Example 4 (Lip cream) (Composition) (% by weight) Candelilla wax 20.0 Carnauba wax 2.0 Shea butter (manufactured by Henkel) 7.0 Hardened castor oil 2.0 Microcrystalline wax 1.0 Castor Oil 68.0 Each component is heated and melted at 80 ° C., put into a mold, and cooled to room temperature.
【図面の簡単な説明】[Brief description of drawings]
【図1】水冷1分後の皮膚温分布を示す図である。FIG. 1 is a diagram showing a skin temperature distribution after 1 minute of water cooling.
【図2】水冷20分後の皮膚温分布を示す図である。FIG. 2 is a diagram showing a skin temperature distribution after 20 minutes of water cooling.
Claims (2)
とする外用血行促進剤。1. A blood circulation promoter for external use, which comprises an oil and fat obtained from seeds of Shea as an active ingredient.
とする外用皮膚温上昇・保持剤。2. An external skin temperature raising / holding agent comprising an oil / fat obtained from shea seeds as an active ingredient.
Priority Applications (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
JP03196708A JP3113705B2 (en) | 1991-08-06 | 1991-08-06 | External preparation |
Applications Claiming Priority (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
JP03196708A JP3113705B2 (en) | 1991-08-06 | 1991-08-06 | External preparation |
Publications (2)
Publication Number | Publication Date |
---|---|
JPH0539225A true JPH0539225A (en) | 1993-02-19 |
JP3113705B2 JP3113705B2 (en) | 2000-12-04 |
Family
ID=16362270
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
JP03196708A Expired - Fee Related JP3113705B2 (en) | 1991-08-06 | 1991-08-06 | External preparation |
Country Status (1)
Country | Link |
---|---|
JP (1) | JP3113705B2 (en) |
Cited By (4)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
WO1996003137A1 (en) * | 1994-07-22 | 1996-02-08 | Henkel Kommanditgesellschaft Auf Aktien | Cosmetic and/or pharmaceutical preparations |
EP0914817A1 (en) * | 1997-10-20 | 1999-05-12 | Chemisch Adviesbureau Drs. J.C.P. Schreuder B.V. | Nipple ointment composition |
EP1609460A1 (en) * | 2004-06-24 | 2005-12-28 | The Procter & Gamble Company | Skin care compositions comprising fatty material having a melting temperature range of 21-40 C |
JP2014521698A (en) * | 2011-08-05 | 2014-08-28 | ステムテック インターナショナル, インコーポレイテッド | Skin care composition containing a combination of natural ingredients |
Families Citing this family (1)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
SE0201566D0 (en) * | 2002-05-27 | 2002-05-27 | Karlshamns Ab | New composition |
-
1991
- 1991-08-06 JP JP03196708A patent/JP3113705B2/en not_active Expired - Fee Related
Cited By (4)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
WO1996003137A1 (en) * | 1994-07-22 | 1996-02-08 | Henkel Kommanditgesellschaft Auf Aktien | Cosmetic and/or pharmaceutical preparations |
EP0914817A1 (en) * | 1997-10-20 | 1999-05-12 | Chemisch Adviesbureau Drs. J.C.P. Schreuder B.V. | Nipple ointment composition |
EP1609460A1 (en) * | 2004-06-24 | 2005-12-28 | The Procter & Gamble Company | Skin care compositions comprising fatty material having a melting temperature range of 21-40 C |
JP2014521698A (en) * | 2011-08-05 | 2014-08-28 | ステムテック インターナショナル, インコーポレイテッド | Skin care composition containing a combination of natural ingredients |
Also Published As
Publication number | Publication date |
---|---|
JP3113705B2 (en) | 2000-12-04 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
JP4659980B2 (en) | Carbon dioxide-containing viscous composition | |
US3711602A (en) | Compositions for topical application for enhancing tissue penetration of physiologically active agents with dmso | |
JP2000319187A (en) | Carbon dioxide transcutaneous and transmucosal absorption composition | |
JP2003528821A (en) | Pharmaceutical and cosmetic carriers or compositions for topical application | |
KR20000052678A (en) | Antiherpetic pharmaceutical compositions containing acyclovir for topical applicators | |
JP2001504463A (en) | Pharmaceutical composition containing Kukunoki nut oil | |
JP2011088930A (en) | Carbon dioxide percutaneous and transmucosal absorption composition | |
HU218921B (en) | Topical use of anorganic salt of stroncium (ii) for producing pharmaceutical compositions for treating neurogen skin-diseases | |
JP5643872B2 (en) | Carbon dioxide transdermal / mucosal absorption composition | |
KR20120107864A (en) | Composition used for treating skin diseases, preparation comprising said composition and production method therefor | |
CN105770237A (en) | Foaming agent with itching-relieving and inflammation-diminishing effects and preparation method of foaming agent | |
JP3113705B2 (en) | External preparation | |
JP5164438B2 (en) | Carbon dioxide transdermal / mucosal absorption composition | |
JP4256125B2 (en) | Composition for external use | |
JP5699184B2 (en) | Carbon dioxide transdermal / mucosal absorption composition | |
CN108771753B (en) | Traumatic injury kaleidoscope oil hard ointment and preparation method thereof | |
JP2001500145A (en) | Formulations for topical use | |
JP5993336B2 (en) | Carbon dioxide transdermal / mucosal absorption composition | |
CN108635556B (en) | Ointment of kaleidoscope oil for traumatic injury and its preparation method | |
RU2190388C1 (en) | Preparation on base of tea tree oil (versions) | |
JPS5988421A (en) | Sebum spread reducing composition | |
JP2013177461A (en) | Composition for percutaneously and transmucosally absorbing carbon dioxide | |
JP2001163777A (en) | Skin lotion | |
CN111514130A (en) | Composition for treating whelk | |
US20190282537A1 (en) | Pharmaceutical composition for treating skin ulcers, injuries and burns |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
R250 | Receipt of annual fees |
Free format text: JAPANESE INTERMEDIATE CODE: R250 |
|
R250 | Receipt of annual fees |
Free format text: JAPANESE INTERMEDIATE CODE: R250 |
|
R250 | Receipt of annual fees |
Free format text: JAPANESE INTERMEDIATE CODE: R250 |
|
R250 | Receipt of annual fees |
Free format text: JAPANESE INTERMEDIATE CODE: R250 |
|
FPAY | Renewal fee payment (event date is renewal date of database) |
Free format text: PAYMENT UNTIL: 20090922 Year of fee payment: 9 |
|
FPAY | Renewal fee payment (event date is renewal date of database) |
Free format text: PAYMENT UNTIL: 20090922 Year of fee payment: 9 |
|
FPAY | Renewal fee payment (event date is renewal date of database) |
Free format text: PAYMENT UNTIL: 20100922 Year of fee payment: 10 |
|
LAPS | Cancellation because of no payment of annual fees |